...
首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Profound Depletion of Host Conventional Dendritic Cells, Plasmacytoid Dendritic Cells, and B Cells Does Not Prevent Graft-versus-Host Disease Induction.
【24h】

Profound Depletion of Host Conventional Dendritic Cells, Plasmacytoid Dendritic Cells, and B Cells Does Not Prevent Graft-versus-Host Disease Induction.

机译:宿主常规树突状细胞,浆细胞样树突状细胞和B细胞的严重耗竭并不能阻止移植物抗宿主病的诱导。

获取原文
获取原文并翻译 | 示例
           

摘要

The efficacy of allogeneic hematopoietic stem cell transplantation is limited by graft-versus-host disease (GVHD). Host hematopoietic APCs are important initiators of GVHD, making them logical targets for GVHD prevention. Conventional dendritic cells (DCs) are key APCs for T cell responses in other models of T cell immunity, and they are sufficient for GVHD induction. However, we report in this article that in two polyclonal GVHD models in which host hematopoietic APCs are essential, GVHD was not decreased when recipient conventional DCs were inducibly or constitutively deleted. Additional profound depletion of plasmacytoid DCs and B cells, with or without partial depletion of CD11b(+) cells, also did not ameliorate GVHD. These data indicate that, in contrast with pathogen models, there is a surprising redundancy as to which host cells can initiate GVHD. Alternatively, very low numbers of targeted APCs were sufficient. We hypothesize the difference in APC requirements in pathogen and GVHD models relates to the availability of target Ags. In antipathogen responses, specialized APCs are uniquely equipped to acquire and present exogenous Ags, whereas in GVHD, all host cells directly present alloantigens. These studies make it unlikely that reagent-based host APC depletion will prevent GVHD in the clinic.
机译:异体造血干细胞移植的功效受到移植物抗宿主病(GVHD)的限制。宿主造血APC是GVHD的重要发起者,使其成为预防GVHD的逻辑目标。在其他T细胞免疫模型中,常规树突细胞(DC)是T细胞反应的关键APC,它们足以诱导GVHD。但是,我们在这篇文章中报告说,在其中宿主造血APC是必不可少的两个多克隆GVHD模型中,当诱导性或组成性删除受体常规DC时,GVHD不会降低。浆细胞样DCs和B细胞的其他大量消耗,无论是否存在CD11b(+)细胞的部分消耗,都不能改善GVHD。这些数据表明,与病原体模型相比,在哪些宿主细胞可以启动GVHD方面存在令人惊讶的冗余。另外,极少量的目标APC就足够了。我们假设病原体和GVHD模型中APC要求的差异与目标Ag的可用性有关。在抗病原体反应中,专门的APC具有独特的能力来获取和呈递外源Ag,而在GVHD中,所有宿主细胞都直接呈递同种抗原。这些研究使得基于试剂的宿主APC耗竭不可能在临床上预防GVHD。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号